Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease

MI Fonseca, RR Ager, SH Chu, O Yazan… - The Journal of …, 2009 - journals.aai.org
Alzheimer's disease (AD) is an age-related dementia, characterized by amyloid plaques,
neurofibrillary tangles, neuroinflammation, and neuronal loss in the brain. Components of …
被引用次数：285 相关文章

Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease.

MI Fonseca, RR Ager, SH Chu, O Yazan… - … (Baltimore, Md.: 1950 …, 2009 - europepmc.org
Alzheimer's disease (AD) is an age-related dementia, characterized by amyloid plaques,
neurofibrillary tangles, neuroinflammation, and neuronal loss in the brain. Components of …

[引用][C] Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease

MI Fonseca, RR Ager, SH Chu… - Journal of …, 2009 - espace.library.uq.edu.au
Alzheimer's disease (AD) is an age-related dementia, characterized by amyloid plaques,
neurofibrillary tangles, neuroinflammation, and neuronal loss in the brain. Components of …
[PDF] academia.edu

[PDF][PDF] Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease

MI Fonseca, RR Ager, SH Chu, O Yazan… - Journal of …, 2009 - academia.edu
Alzheimer's disease (AD) is an age-related dementia, characterized by amyloid plaques,
neurofibrillary tangles, neuroinflammation, and neuronal loss in the brain. Components of …

Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease

MI Fonseca, RR Ager, SH Chu, O Yazan… - The Journal of …, 2009 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Alzheimer's disease (AD) is an age-related
dementia, characterized by amyloid plaques, neurofibrillary tangles, neuroinflammation, and …
[PDF] researchgate.net

[PDF][PDF] Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease

MI Fonseca, RR Ager, SH Chu, O Yazan… - Journal of …, 2009 - researchgate.net
Alzheimer's disease (AD) is an age-related dementia, characterized by amyloid plaques,
neurofibrillary tangles, neuroinflammation, and neuronal loss in the brain. Components of …
[HTML] nih.gov

[HTML][HTML] Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease

MI Fonseca, RR Ager, SH Chu, O Yazan… - … (Baltimore, Md.: 1950 …, 2009 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is an age-related dementia, characterized by amyloid plaques,
neurofibrillary tangles, neuroinflammation, and neuronal loss in the brain. Components of …

Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease

MI Fonseca, RR Ager, SH Chu… - Journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is an age-related dementia, characterized by amyloid plaques,
neurofibrillary tangles, neuroinflammation, and neuronal loss in the brain. Components of …

Treatment with a C5aR Antagonist Decreases Pathology and Enhances Behavioral Performance in Murine Models of Alzheimer's Disease

MI Fonseca, RR Ager, SH Chu, O Yazan… - The Journal of …, 2009 - journals.aai.org
Alzheimer's disease (AD) is an age-related dementia, characterized by amyloid plaques,
neurofibrillary tangles, neuroinflammation, and neuronal loss in the brain. Components of …

Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease

MI Fonseca, RR Ager, SH Chu, O Yazan… - Journal of …, 2009 - experts.nebraska.edu
Alzheimer's disease (AD) is an age-related dementia, characterized by amyloid plaques,
neurofibrillary tangles, neuroinflammation, and neuronal loss in the brain. Components of …